Elina Haavisto
MSc, Head of CMC Regulatory Affairs
Head of CMC Regulatory Affairs, Elina Haavisto, has over a decade’s experience of clinical and industrial experience in oncolytic adenoviruses. Elina has worked at Oncos Therapeutics Ltd. (now Targovax ASA), and has broad experience in CMC, regulatory and adenovirus GMP manufacturing. Elina is responsible for the management of the outsourced virus manufacturing and logistics with the clinical trial sites, as well as preparation of CMC regulatory documentation.
